(S)-2-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-8-((1H-咪唑-5-基)甲基)-2,20,26- 三(3-胍基丙基)-11-(羟甲基)-5,17,29-三异丁基-23-异丙基-14-甲基-4,7,10,13,16,19,22,25,28,31-十氧代 -3,6,9,12,15,18,21,24,27,30-十氮杂三甲酰胺)-6-氨基-N-((4S,7S,10S,13S,16S,19S)-13-(4- 氨基丁基)-4-氨基甲酰基-10,16-双(3-胍基丙基)
Cog 133 trifluoroacetate
(S)-2-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-8-((1H-咪唑-5-基)甲基)-2,20,26- 三(3-胍基丙基)-11-(羟甲基)-5,17,29-三异丁基-23-异丙基-14-甲基-4,7,10,13,16,19,22,25,28,31-十氧代 -3,6,9,12,15,18,21,24,27,30-十氮杂三甲酰胺)-6-氨基-N-((4S,7S,10S,13S,16S,19S)-13-(4- 氨基丁基)-4-氨基甲酰基-10,16-双(3-胍基丙基) 98%